Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain

Open Access

Peer-reviewed

Research Article

Katrina Weston-Green,

Affiliations Centre for Translational Neuroscience, School of Health Sciences, University of Wollongong, Wollongong, Australia, Schizophrenia Research Institute, Darlinghurst, Australia
⨯
Xu-Feng Huang,

Affiliations Centre for Translational Neuroscience, School of Health Sciences, University of Wollongong, Wollongong, Australia, Schizophrenia Research Institute, Darlinghurst, Australia
⨯
Chao Deng

* E-mail: chao@uow.edu.au

Affiliations Centre for Translational Neuroscience, School of Health Sciences, University of Wollongong, Wollongong, Australia, Schizophrenia Research Institute, Darlinghurst, Australia
⨯

Reader Comments (0)

Weight gain
Is the Subject Area "Weight gain" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Gamma-aminobutyric acid
Is the Subject Area "Gamma-aminobutyric acid" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.
Cannabinoids
Is the Subject Area "Cannabinoids" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Drug metabolism
Is the Subject Area "Drug metabolism" applicable to this article?

Thanks for your feedback.
Obesity
Is the Subject Area "Obesity" applicable to this article?

Thanks for your feedback.